The United States Department of Justice (DOJ) recently announced that Teva Pharmaceuticals USA Inc. and Teva Neuroscience Inc. will pay $450 million to resolve allegations of violating the ...
Teva Pharmaceutical Industries Ltd has agreed to pay $450 million to resolve allegations it used charities that help cover ...
Teva Pharmaceuticals has agreed to pay $425 million to resolve allegations that the company ... submission of false claims to Medicare. 2. The settlement was reached after the government's review ...
Some two years after the European Commission accused Teva of meddling with the competition for its former multiple sclerosis blockbuster Copaxone, the other shoe has finally dropped. | The European ...
Teva Pharmaceuticals TEVA-0.81%decrease; red down pointing triangle will pay $450 million to resolve allegations that ... Department on Thursday said the settlement amount was based on the company ...
Today's decision to impose an antitrust fine on Teva for disparagement and misuse of the patent system reaffirms the ...
(RTTNews) - Teva Pharmaceuticals (TEVA) has agreed to pay $450 million in a settlement under the False Claims Act to resolve allegations related to kickbacks concerning copayments and price fixing ...
The European Commission has fined Israeli generic drugmaker Teva more than 460 million euros ($500 million) for improperly ...
South Dakota will receive almost $300,000 as part of a settlement with global health company Apotex and Teva Pharmaceuticals ...
In the largest settlement of its kind, Teva Pharmaceuticals agreed to pay $425 million to resolve allegations the company and a related business paid kickbacks to charitable foundations in order ...
State attorneys general have reached a settlement over price-fixing by generic drugmakers for the first time since they began probing the issue a decade ago.
The European Commission has fined Teva , the world's largest generic drugmaker, 462.6 million euros ($503 million) for abusing its dominant position to delay competition to its blockbuster multiple ...